GRMLHIGH SIGNALFINANCIAL10-K

GRML shows deteriorating financial performance with substantially higher operating losses and dramatically reduced liabilities, while outstanding shares increased roughly four-fold.

The company's operating performance has meaningfully worsened with expanded losses across key metrics, suggesting ongoing operational challenges or increased investment spending. However, the dramatic reduction in total liabilities from $1.3M to $130K represents a significant improvement in the company's debt position, potentially through debt restructuring or settlement.

Comparing 2026-04-01 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

GRML's financial picture shows mixed signals with meaningfully higher operating losses and substantially increased cash outflows from operations. The company's balance sheet improved notably with current liabilities declining 94% and total liabilities falling 90%, suggesting significant debt reduction or restructuring. The four-fold increase in outstanding shares from 28.5M to 121.2M indicates substantial equity issuance, likely used to address the liability reduction and fund operations despite the expanded losses.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
-99.9%
-$2.9M-$5.9M

Operating cash flow fell 99.9% — earnings quality concerns; investigate working capital changes and non-cash items.

Current Liabilities
Balance Sheet
-93.8%
$1.2M$77K

Current liabilities reduced — improved short-term financial position and working capital health.

Total Liabilities
Balance Sheet
-89.8%
$1.3M$130K

Liabilities reduced 89.8% — deleveraging improves balance sheet strength and financial flexibility.

Net Income
P&L
-71.6%
-$6.2M-$10.6M

Net income declined 71.6% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-29%
-$5.5M-$7.1M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

LANGUAGE CHANGES
NEW — 2026-04-01
PRIOR — 2025-03-31
ADDED
Employer Identification No.) 1300 South Boulevard , Unit D Charlotte , NC 28203 (Address of principal executive offices) (Zip Code) (833) 931-6330 (Registrant s telephone number, including area code) Klotho Neurosciences, Inc.
As of March 31, 2026, there were 121,238,660 shares of the registrant s common stock, $0.0001 par value, issued and outstanding.
FORM 10-K SUMMARY 68 SIGNATURES 69 i Introductory Comment Throughout this Annual Report on Form 10-K, the terms we, us, our, our company, Greenland Mines Ltd, Klotho Neurosciences, Inc., the Company and the Registrant refer to Greenland Mines Ltd.
For example, statements regarding our financial position, business strategy and other plans and objectives for future operations, and assumptions and predictions about future product demand, supply, manufacturing, costs, marketing and pricing factors are all forward-looking statements.
These statements are generally accompanied by words such as intend, anticipate, believe, estimate, potential(ly), continue, forecast, predict, plan, may, will, could, would, should, expect or the negative of such terms or other comparable terminology.
We believe that the assumptions and expectations reflected in such forward-looking statements are reasonable, based on information available to us on the date hereof, but we cannot assure you that these assumptions and expectations will prove to have been correct or that we will take any action that we may presently be planning.
However, these forward-looking statements are inherently subject to known and unknown risks and uncertainties.
Factors that could cause or contribute to such differences include, but are not limited to, regulatory policies, competition from other similar businesses, and market and general policies, competition from other similar businesses, and market and general economic factors.
This discussion should be read in conjunction with the consolidated financial statements and notes thereto included in this Report.
If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we project.
REMOVED
(Exact name of registrant as specified in its charter) Delaware 86-2727441 (State or other jurisdiction of incorporation or organization) (I.R.S.
As of March 31, 2025, there were 28,510,632 shares of the registrant s common stock, $0.0001 par value, issued and outstanding.
FORM 10-K SUMMARY 70 SIGNATURES 71 i CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Current Report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws regarding, among other things, the plans, strategies, and prospects, both business and financial, of Klotho Neurosciences, Inc.
These statements are based on the beliefs and assumptions of the management of Klotho.
Although Klotho believes that its plans, intentions, and expectations reflected in or suggested by these forward-looking statements are reasonable, Klotho cannot assure you that it will achieve or realize these plans, intentions, or expectations.
Forward-looking statements are inherently subject to numerous risks, uncertainties, and assumptions.
Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, are forward-looking statements.
These statements may be preceded by, followed by or include the words aim, anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, project, should, would or similar expressions, but the absence of these words does not mean that a statement is not forward-looking.
Any forward-looking statements are based on information available as of the date of this Current Report on Form 10-K, and current expectations, forecasts, and assumptions, and involve a number of risks and uncertainties.
Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →